Innomed Technologies, Inc. Introduces Nasal Aire to Public; 98% Choose Nasal Aire in Clinical Trials

Monday, October 15, 2001

NEW ORLEANS--(BUSINESS WIRE)--

Innomed Technologies, Inc., a Boca Raton based medical technology company for the respiratory and sleep apnea markets, is proud to introduce the FDA approved Nasal Aire(TM) interface this October 23rd at Med Trade 2001 in New Orleans - booth 778. Med Trade is the world's largest home health care exhibition. This will be the first time the public will be able to review the highly anticipated Nasal Aire(TM) device.
Innomed Technologies, Inc. also announced that clinical trials for the Nasal Aire(TM) are complete, with further testing scheduled for early next year. Patrick Karem, president of Innomed Technologies, Inc. was quoted as saying, "We felt that the clinical results from the Nasal Aire(TM) were nothing short of spectacular. Independent studies have shown that when patients are given a choice between using the Nasal Aire(TM) or the 3 leading competitive masks, manufactured by Resmed, Inc. (RMD) and Respironics (RESP), 98% of the time the Nasal Aire(TM) was chosen. That's impressive. We are also hearing from clinicians conducting the trials that they are able to titrate patients with less pressure, that there are trace amounts of or zero leakage. Also, CO2 retention appears to be the lowest of any device. We are very pleased with these results and they show the medical community just how well this innovative product works."

Innomed Technologies, Inc. will also be showing the NASAL AIRE(TM) at the AARC meeting in San Antonio in early December.

About Innomed Technologies, Inc.

Innomed Technologies, Inc. is a 21st Century medical technologies company. The company is poised to bring new and more effective medical products and devices to the public through a medical development and engineering team, as well as acquisitions of other medical related companies. Innomed Technologies, Inc. has primarily been a research oriented, privately held, medical technology development company for the past 4 years. The company owns a full utility patent and patents pending.

A Private Securities Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Certain information included in this press release (as well as information included in written statements to be made) contain statements that are forward-looking, such as those relating to consummation of the transaction, anticipated future revenue of the Company's, and success of current public offerings. Such forward-looking information involves important risks and uncertainties that could significantly affect anticipated results in the future and, accordingly, such results may differ materially from those expressed in any forward looking statements.